Market Overview

Bank of America Maintains Neutral on The Medicines Company, Raises PO to $28.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MDCO

DateFirmActionFromTo
Apr 2014Leerink SwannDowngradesOutperformMarket Perform
Apr 2014Piper JaffrayDowngradesOverweightNeutral
Feb 2014JefferiesDowngradesBuyHold

View More Analyst Ratings for MDCO
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (MDCO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters